CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistance
Open Access
- 21 December 2024
- journal article
- letter
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 25 (1) , 1-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach2021
- iCSDB: an integrated database of CRISPR screensNucleic Acids Research, 2020
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screensNature, 2019
- Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell linesGenome Biology, 2014